Viewing Study NCT00885534

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:33 AM
Ignite Modification Date: 2026-01-09 @ 4:08 AM
Study NCT ID: NCT00885534
Status: COMPLETED
Last Update Posted: 2015-05-06
First Post: 2009-04-21
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
None Skin Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None skin cancer View
None CISPLATIN View
None TEMOZOLOMIDE View
None VINBLASTINE View
None 09-017 View